Table 4 Relationship between the expression of SOX2 and CD133 or p63 in squamous cell carcinomas of the esophagus*

From: SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation

 

CD133

 

Negative

Focal

Moderate

Extensive

SOX2

 Negative

7

1

0

0

 Focal

2

1

0

0

 Moderate

6

5

2

1

 Extensive

70

10

4

4

 

p63

 

0

1+

2+

3+

SOX2

 Negative

0

1

0

7

 Focal

0

0

1

2

 Moderate

0

1

0

13

 Extensive

0

4

2

82

  1. Negative, no expression; focal, positive in 1–25% of cancer cells, moderate, 26–50%; extensive, >50%. *No correlation found in either comparison (P>0.05).
Back to article page